← Open Payments lookup

SHAHNAZ MULLA: Open Payments

NPI 1013546662 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,788 in 93 payments from 16 companies in 2025. Trend: 2023 $37 · 2024 $1,126 · 2025 $1,788

Food & beverage: $1,788
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)10$199
Lundbeck LLC8$193
ABBVIE INC.15$190
Corium, LLC10$171
Janssen Pharmaceuticals, Inc6$162
Noven Therapeutics, LLC13$159
Otsuka America Pharmaceutical, Inc.6$144
Tris Pharma Inc6$123
Neurocrine BioSciences, Inc.4$101
Takeda Pharmaceuticals U.S.A., Inc.4$90

Products named: REXULTI, CAPLYTA, VRAYLAR, Azstarys, SPRAVATO, Xelstrym, Dyanavel XR, INGREZZA.

Industry payments across GA — which companies pay providers there.